Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)

NCT05758883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2024-04-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term safety of the IC-8 Apthera intraocular lens (IOL).

Conditions

Sponsors & Collaborators

  • AcuFocus, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-12
Primary Completion
2024-02-16
Completion
2024-02-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05758883 on ClinicalTrials.gov